Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by DeepCure

DeepCure Unveils STAT6 Inhibitor Program with Novel Oral Small Molecules Targeting Type 2 Inflammation
From DeepCure
Via Business Wire
DeepCure to Present First Ex Vivo Rheumatoid Arthritis Patient Data for Selective BRD4 (BD2) Inhibitor DC-9476 at ACR Convergence 2024
From DeepCure
Via Business Wire
DeepCure to Participate in Upcoming Investor Conferences
From DeepCure
Via Business Wire
DeepCure to Present In Vivo Data Showing Its Selective BRD4 (BD2) Inhibitor DC-9476 is Superior to Etanercept in Rheumatoid Arthritis
From DeepCure
Via Business Wire
DeepCure to Present In Vivo Efficacy and Safety Data of BRD4 (BD2) Inhibitor DC-9476 for Macrophage Activation Syndrome at EMBO Conference
From DeepCure
Via Business Wire
DeepCure Announces Collaboration with Leeds Institute to Evaluate DC-9476 in Rheumatoid Arthritis
From DeepCure
Via Business Wire
DeepCure Announces Selection of First AI-Generated Candidate DC-9476 for Autoimmune Diseases
From DeepCure
Via Business Wire
DeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough
From DeepCure
Via Business Wire
DeepCure Closes $24M Funding Round Led by IAG Capital Partners
From DeepCure
Via Business Wire
DeepCure Closes $40M Series A Funding Led by Morningside Ventures
From DeepCure
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.